The AVA Annual Conference is the nation’s premier veterinary event, covering all fields of veterinary science and in 2017 brought together over 920 veterinary professionals and 115 exhibitors.

We hope you will join us for the 2018 AVA Annual Conference in Brisbane, 13-18 May.    
Visit conference.ava.com.au to register.    To download a pdf file of the entire program click here.
Thursday, May 17 • 12:00pm - 12:30pm
The Integration of standard treatment for canine mitral valve disease and dilated cardiomyopathy, with complimentary therapies

Sign up or log in to save this to your schedule and see who's attending!

Canine Cardiac Disease classification Canine Cardiac disease is defined as occurring four stages: A, B C and D. A is asymptomatic but at risk, according to breed dynamics. B is symptomatic on clinical examination, but compensated so that owners are unaware of any problems. C shows overt disease, and D has progressed to uncompensated heart failure. Standard treatments include enapril, frusemide and primabendin in late Stage B depending on the level of compensation, and C and D. Complimentary therapies It is possible that intervening with complimentary therapies in early stages will slow disease progression, reduce dose rate and frequency of standard medications when these are needed, and reduce the time in hospital. Gut dysbiosis affects the metabolism from an early age. Care should be taken with cesarian births, and gut flora balance rectified as soon as possible. Taurine, Coenzyme Q 10, Acetyl l Carnitine and Mussel extract, EPA/ DHA are nutritional supplements, which can improve heart function and be added to the food. Hawthorne, Siberian Ginseng and Kumbuk (Arjuna) are herbs which have long historical use in improving human heart function, and are used extensively today in dogs. Their functions are described, and their use with structural therapies.


Thursday May 17, 2018 12:00pm - 12:30pm
Plaza P2 Brisbane Convention and Exhibition Centre